Matches in Nanopublications for { ?s ?p "[The risk of endometrial cancer in the entire group of EPCAM deletion carriers is significantly lower than that in MSH2 mutation carriers, but the actual risk appears to be dependent on the size and location of the EPCAM deletion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP542513.RADtCMXg5VtONem_zlkDMle0pXq7aL3j-C9JKvcU-UzzI130_assertion description "[The risk of endometrial cancer in the entire group of EPCAM deletion carriers is significantly lower than that in MSH2 mutation carriers, but the actual risk appears to be dependent on the size and location of the EPCAM deletion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP542513.RADtCMXg5VtONem_zlkDMle0pXq7aL3j-C9JKvcU-UzzI130_provenance.
- NP569707.RAZjWP2IbwGnidf8P-Pv4fZAibf_rOzoDQdpUJcKpD6N4130_assertion description "[The risk of endometrial cancer in the entire group of EPCAM deletion carriers is significantly lower than that in MSH2 mutation carriers, but the actual risk appears to be dependent on the size and location of the EPCAM deletion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP569707.RAZjWP2IbwGnidf8P-Pv4fZAibf_rOzoDQdpUJcKpD6N4130_provenance.
- NP570363.RAWGNj05GHlR-6W4VhkJthWkFIoXvVt_kb6BmgHI6M1T4130_assertion description "[The risk of endometrial cancer in the entire group of EPCAM deletion carriers is significantly lower than that in MSH2 mutation carriers, but the actual risk appears to be dependent on the size and location of the EPCAM deletion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP570363.RAWGNj05GHlR-6W4VhkJthWkFIoXvVt_kb6BmgHI6M1T4130_provenance.
- NP1038338.RA5ZGQHY__Td-6-KxOl9UzCWCmlmj5GBuRueji937XSxo130_assertion description "[The risk of endometrial cancer in the entire group of EPCAM deletion carriers is significantly lower than that in MSH2 mutation carriers, but the actual risk appears to be dependent on the size and location of the EPCAM deletion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1038338.RA5ZGQHY__Td-6-KxOl9UzCWCmlmj5GBuRueji937XSxo130_provenance.
- NP1038344.RA3jxhv2TNi7cv4QpzTbORCZhIhAOU_UYl2eKyYRpWgTs130_assertion description "[The risk of endometrial cancer in the entire group of EPCAM deletion carriers is significantly lower than that in MSH2 mutation carriers, but the actual risk appears to be dependent on the size and location of the EPCAM deletion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1038344.RA3jxhv2TNi7cv4QpzTbORCZhIhAOU_UYl2eKyYRpWgTs130_provenance.
- NP542645.RAN6U9vj06IWeV0Z-eaJ0Lk_zwPxu_85qyokqis5hiM3Q130_assertion description "[The risk of endometrial cancer in the entire group of EPCAM deletion carriers is significantly lower than that in MSH2 mutation carriers, but the actual risk appears to be dependent on the size and location of the EPCAM deletion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP542645.RAN6U9vj06IWeV0Z-eaJ0Lk_zwPxu_85qyokqis5hiM3Q130_provenance.
- NP1038335.RAXZjFjfqORL1Il3cC8KzK4q5fjbf6NrIPX7jTJ8T9nMs130_assertion description "[The risk of endometrial cancer in the entire group of EPCAM deletion carriers is significantly lower than that in MSH2 mutation carriers, but the actual risk appears to be dependent on the size and location of the EPCAM deletion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1038335.RAXZjFjfqORL1Il3cC8KzK4q5fjbf6NrIPX7jTJ8T9nMs130_provenance.
- NP1038340.RAUavrE6p3vu79086MvsSwXi-PJLzJ_oSsqp7Ae8pZasQ130_assertion description "[The risk of endometrial cancer in the entire group of EPCAM deletion carriers is significantly lower than that in MSH2 mutation carriers, but the actual risk appears to be dependent on the size and location of the EPCAM deletion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1038340.RAUavrE6p3vu79086MvsSwXi-PJLzJ_oSsqp7Ae8pZasQ130_provenance.
- NP542321.RAvQSQ1I8hI-5CPXcE_iShwjkY9AqNZpnnZofZagJOC8s130_assertion description "[The risk of endometrial cancer in the entire group of EPCAM deletion carriers is significantly lower than that in MSH2 mutation carriers, but the actual risk appears to be dependent on the size and location of the EPCAM deletion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP542321.RAvQSQ1I8hI-5CPXcE_iShwjkY9AqNZpnnZofZagJOC8s130_provenance.
- NP570121.RAoPmMoUHVJl8ZP54qGxBdqtz8M92JEfTeto7atMMP1xk130_assertion description "[The risk of endometrial cancer in the entire group of EPCAM deletion carriers is significantly lower than that in MSH2 mutation carriers, but the actual risk appears to be dependent on the size and location of the EPCAM deletion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP570121.RAoPmMoUHVJl8ZP54qGxBdqtz8M92JEfTeto7atMMP1xk130_provenance.
- NP1038342.RAPkZs7ShcIShW0MvPlS8bQj-3eJYlcCVYRpv0F1kFO6I130_assertion description "[The risk of endometrial cancer in the entire group of EPCAM deletion carriers is significantly lower than that in MSH2 mutation carriers, but the actual risk appears to be dependent on the size and location of the EPCAM deletion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1038342.RAPkZs7ShcIShW0MvPlS8bQj-3eJYlcCVYRpv0F1kFO6I130_provenance.
- NP1038337.RAorJ9d1s82G78o_O9xx8wDsbpywCxp0mpLq9GlkHzw3w130_assertion description "[The risk of endometrial cancer in the entire group of EPCAM deletion carriers is significantly lower than that in MSH2 mutation carriers, but the actual risk appears to be dependent on the size and location of the EPCAM deletion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1038337.RAorJ9d1s82G78o_O9xx8wDsbpywCxp0mpLq9GlkHzw3w130_provenance.